AI-generated summary
The authors developed gold nanocages coated with cancer cell membrane and loaded with the drug doxorubicin, then tested them in laboratory and animal studies. They report higher drug loading, near-infrared laser-triggered drug release, reduced macrophage uptake, and complete tumor ablation with reduced inflammatory response. The abstract does not state the number of animals used.
- Who or what was studied
- Tumor-bearing animals and cancer cells in laboratory and in vivo experiments; the abstract does not specify the species or number.
- Limits stated in the abstract
- The abstract does not state the number of animals or give details of the in vivo design, and the work is preclinical.
Written by an AI model from this paper’s abstract only and checked automatically against it, but it can still be wrong. It is not medical advice. Read the full paper. See the editorial policy.
Abstract
The full abstract is not shown here because it is protected by the publisher’s copyright. Read it on thno.org.
Record from PubMed, a service of the National Library of Medicine.
How to read a single study: what to check before relying on this kind of research.
Terms in this paper: Inflammation, Near-infrared, Laser. Each links to its definition in the glossary.
A summary of published research, not medical advice. One study rarely settles a question. See the disclaimer and how to read research.